Tests for Neurological Disorders
Back to Search Results
Featured Topic Archive
September 2010
Autoantibody tests performed on serum and spinal fluid aid in the diagnosis of autoimmune disorders of the brain, nerve, and muscle that are often a reflection of immune responses initiated by unsuspected cancer. These disorders are commonly mistaken for multiple sclerosis, stroke, and untreatable degenerative disorders.
Dysautonomias
- Autoimmune Dysautonomia Evaluation, Serum
The most commonly encountered autoantibody marker of autoimmune dysautonomia is the neuronal ganglionic alpha-3-AChR autoantibody (Ab). Importantly, cancer is detected in 30% of patients with alpha-3-AChR Ab. MORE > - Autoimmune Gastrointestinal Dysmotility Evaluation, Serum
Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia that is sometimes a paraneoplastic disorder. Neoplasms found most commonly are lung cancer, thymoma and miscellaneous adenocarcinomas. MORE > - Familial Dysautonomia, Mutation Analysis
Mutations in the gene encoding IkappaB kinase complex-associated proteins (IKBKAP) cause the clinical findings of familial dysautonomia. The carrier rate in the Ashkenazi Jewish population is 1/31. MORE >
Lambert-Eaton Syndrome (LES)
- Myasthenia Gravis (MG)/Lambert-Eaton Syndrome (LES) Evaluation
A patient's autoantibody profile is more informative than the result of any single test for supporting a diagnosis of Myasthenia Gravis (MG) or Lambert-Eaton syndrome (LES), and for predicting the likelihood of lung carcinoma. MORE >
Myasthenia Gravis (MG)
- Acetylcholine Receptor (Muscle AChR) Binding Antibody, Serum
The assay for muscle AChR binding antibodies is considered a first-order test for the laboratory diagnosis of MG, and for detecting "subclinical MG" in recipients of D-penicillamine, in patients with thymoma without clinical evidence of MG, and in patients with graft-versus-host disease. MORE > - Myasthenia Gravis (MG) Evaluation, Adult
The patient's autoantibody profile is more informative than the result of any single test for supporting a diagnosis of MG, and for predicting the likelihood of thymoma. MORE > - Myasthenia Gravis (MG) Evaluation, Pediatric
Seronegativity is more frequent in children with prepubertal onset of acquired MG (33%-50%) than in adults (<10%). Thymoma is rare under age 20, and striational antibodies... also are rare, except in the context of MG related to neoplasia (usually thymoma or neuroblastoma), graft-versus-host disease, autoimmune liver disease, or D-penicillamine therapy. MORE > - Myasthenia Gravis (MG) Evaluation, Thymoma
It is estimated that approximately 20% of adult patients have a paraneoplastic basis for MG. Thymoma is the most common neoplasm, often occult at the onset of MG, its diagnosis may precede MG onset. MORE > - Myasthenia Gravis (MG)/Lambert-Eaton Syndrome (LES) Evaluation
A patient's autoantibody profile is more informative than the result of any single test for supporting a diagnosis of Myasthenia Gravis (MG) or Lambert-Eaton syndrome (LES), and for predicting the likelihood of lung carcinoma. MORE > - Striational (Striated Muscle) Antibodies, Serum
Autoantibodies directed against the contractile elements of striatedmuscle are found in 30% of adult patients with myasthenia gravis (MG) and in 80% of those with thymoma. MORE >
Neuromuscular Hyperexcitability
- Autoimmune Dysautonomia Evaluation, Serum
The most commonly encountered autoantibody marker of autoimmune dysautonomia is the neuronal ganglionic alpha-3-AChR autoantibody (Ab).... Importantly, cancer is detected in 30% of patients with alpha-3-AChR Ab.MORE > - Glutamic Acid Decarboxylase (GAD65), Serum
Antibodies directed against the 65-kd isoform of GAD(GAD65) are seen in a variety of autoimmune neurologic disorders including stiff-man (Moersch-Woltman) syndrome, autoimmunecerebellitis, brain stem encephalitis, seizure disorders, neuromyelitisoptica and other myelopathies, myasthenia gravis, Lambert-Eaton syndrome, and dysautonomia. MORE > - Paraneoplastic Autoantibody Evaluation, Serum
Paraneoplastic autoimmune neurological disorders reflect a patient's humoral and cellular immune responses to cancer. The cancer may be new or recurrent, is usually limited in metastatic volume, and is often occult by standard imaging procedures. MORE >
Neuromyelitis Optica (NMO) Spectrum Disorders
- Neuromyelitis Optica (NMO) Autoantibody, IgG - Serum
Seropositivity for NMO autoantibody IgG (NMO-IgG) allows early diagnostic distinction between NMO (73% positive; 91% specific) and multiple sclerosis (0% positive). NMO-IgG is uniformly negative in patients with classical multiple sclerosis, for which no biomarker is currently recognized. MORE > - Neuromyelitis Optica (NMO) Autoantibody, IgG - Spinal Fluid
Serum is the preferred specimen for detection of NMO-IgG; cerebrospinal fluid is usually less informative. MORE >
Peripheral Nerve Disorders
- Peripheral Nerve Path Consult
Neuropathic abnormalities include decreased density of myelinated fibers, segmental demyelination, and axonal degeneration. Some possible interstitial abnormalities that affect nerves include necrotizing vasculitis and amyloidosis. MORE >
Thymoma
- Myasthenia Gravis (MG) Evaluation, Thymoma
It is estimated that approximately 20% of adult patients have a paraneoplastic basis for MG. Thymoma is the most common neoplasm, often occult at the onset of MG, its diagnosis may precede MG onset. MORE >


